OTC Markets OTCQB USD

Inhibitor Therapeutics, Inc. (INTI)

0.0900 0.0000 (0.00%)
At close: May 29 at 2:37 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
3,550.0720
3,404.9790
657.9260
325.3950
1,058.9970
--
Operating Income
-3,550.0720
-3,404.9790
-657.9260
-325.3950
-1,058.9970
--
Net Non Operating Interest Income Expense
378.8220
378.8440
-23.2340
-14.8370
1.0680
--
Other Income Expense
--
--
12,842.4990
41.6000
--
--
Pretax Income
-3,171.2500
-3,026.1350
12,161.3390
-298.6320
-1,057.9290
--
Tax Provision
--
--
55.1090
--
--
--
Net Income Common Stockholders
-3,171.2500
-3,026.1350
11,917.1880
-498.6330
-1,258.4770
--
Diluted NI Available to Com Stockholders
-3,171.2500
-3,026.1350
11,917.1880
-498.6330
-1,258.4770
--
Basic EPS
-0.02
-0.02
0.03
-0.00
-0.00
--
Diluted EPS
-0.02
-0.02
0.03
-0.00
-0.00
--
Basic Average Shares
172,021.7220
171,950.1080
366,183.6970
376,247.7770
371,927.7340
--
Diluted Average Shares
172,021.7220
171,950.1080
366,183.6970
376,247.7770
371,927.7340
--
Total Operating Income as Reported
-3,550.0720
-3,404.9790
-657.9260
-325.3950
-1,058.9870
--
Total Expenses
3,550.0720
3,404.9790
657.9260
325.3950
1,058.9970
--
Net Income from Continuing & Discontinued Operation
-3,171.2500
-3,026.1350
12,106.2300
-298.6320
-1,057.9290
--
Normalized Income
-3,171.2500
-3,026.1350
-678.0733
-340.2320
-1,057.9290
--
Interest Income
378.8220
378.8440
--
--
1.0680
14.5400
Interest Expense
24.6800
--
23.2340
14.8370
--
--
Net Interest Income
378.8220
378.8440
-23.2340
-14.8370
1.0680
--
EBIT
-3,171.2280
-3,026.1350
12,184.5730
-283.7950
-1,058.9970
--
EBITDA
-3,171.2280
-3,026.1350
12,184.5730
-283.7950
-1,058.9970
--
Net Income from Continuing Operation Net Minority Interest
-3,171.2500
-3,026.1350
12,106.2300
-298.6320
-1,057.9290
--
Total Unusual Items Excluding Goodwill
--
--
12,842.4990
41.6000
--
--
Total Unusual Items
--
--
12,842.4990
41.6000
--
--
Normalized EBITDA
-3,171.2280
-3,026.1350
-657.9260
-325.3950
-1,058.9970
--
Tax Rate for Calcs
--
--
0.0000
--
--
--
Tax Effect of Unusual Items
--
--
58.1957
--
--
--
12/31/2019 - 9/13/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VXLLF Vaxil Bio Ltd.
0.0080
0.00%
 
TELO Telomir Pharmaceuticals, Inc.
5.63
+8.69%
 
RENB Renovaro Inc.
1.2900
-3.01%
 
MYMD MyMD Pharmaceuticals, Inc.
1.9500
+2.09%
 
BCTX BriaCell Therapeutics Corp.
1.3900
-2.80%
 
NKGN NKGen Biotech, Inc.
1.4500
+5.84%
 
MDMA.CN Pharmala Biotech Holdings Inc.
0.1150
-4.17%
 
LIFE aTyr Pharma, Inc.
1.9000
+2.70%
 
ATNM Actinium Pharmaceuticals, Inc.
7.96
-0.38%
 
AVXL Anavex Life Sciences Corp.
3.8700
-3.97%